Different MAPK signal transduction pathways play different roles in the impairment of glucose‑stimulated insulin secretion in response to IL‑1β

Ou,Yang; Zheng,Zhongxiong; Niu,Ben; Su,Jian; Su,Heng

doi:10.3892/mmr.2020.11366

Different MAPK signal transduction pathways play different roles in the impairment of glucose‑stimulated insulin secretion in response to IL‑1β

Authors:
- Yang Ou
- Zhongxiong Zheng
- Ben Niu
- Jian Su
- Heng Su
View Affiliations

Affiliations: Faculty of Environmental Science and Engineering, Kunming University of Science and Technology, Kunming, Yunnan 650500, P.R. China, Department of Endocrinology and Metabolism, First People's Hospital of Yunnan Province, Kunming, Yunnan 650032, P.R. China
Published online on: July 28, 2020 https://doi.org/10.3892/mmr.2020.11366
Pages: 2973-2980

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Mitogen‑activated protein kinase (MAPK) signal transduction pathways may be involved in the destruction of pancreatic islet β cells induced by inflammatory cytokines. The present study aimed to investigate the role of different MAPK signal transduction pathways in the interleukin‑1β (IL‑1β)‑induced inhibition of glucose‑stimulated insulin secretion (GSIS) in Min6 mouse pancreatic cells. Min6 cells were stimulated with different concentrations of glucose (0.0, 5.5, 11.1 and 22.2 mmol/l), or different concentrations of IL‑1β (0.00, 0.25 and 2.50 ng/ml) in combination with high glucose (22.2 mmol/l) and the culture supernatant was collected. The concentration of insulin was measured by enzyme‑linked immunosorbent assay and the activation of different MAPK pathways was assessed by measuring the phosphorylation levels of extracellular signal‑regulated kinase 1/2 (ERK1/2), p38 and c‑jun N‑terminal kinase (JNK) via western blotting. The production of reactive oxygen species (ROS) was determined via flow cytometry, and cell viability was detected by Cell Counting Kit‑8 assay. Reverse transcription‑quantitative PCR was used to detect the insulin 1 gene. The results revealed that glucose activated ERK1/2 phosphorylation, but inhibited JNK and p38 phosphorylation in a concentration‑dependent manner. Furthermore, IL‑1β inhibited glucose‑stimulated insulin secretion in a dose‑dependent manner. Western blotting revealed that IL‑1β inhibited the activation of ERK1/2 phosphorylation and attenuated the inhibition of p38 phosphorylation induced by glucose stimulation. JNK was neither activated nor inhibited by IL‑1β. These results suggest that MAPK signal transduction pathways participated in the IL‑1β‑induced GSIS inhibition in Min6 cells, with the ERK1/2, JNK and p38 signaling pathways playing different roles.

View Figures

View References

1	Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, et al 2010 China Noncommunicable Disease Surveillance Group, : Prevalence and control of diabetes in Chinese adults. JAMA. 310:2973–959. 2013. View Article : Google Scholar
2	Kim KA and Lee MS: Recent progress in research on β-cell apoptosis by cytokines. Front Biosci. 14:657–664. 2009. View Article : Google Scholar
3	Ehses JA, Ellingsgaard H, Böni-Schnetzler M and Donath MY: Pancreatic islet inflammation in type 2 diabetes: From alpha and β cell compensation to dysfunction. Arch Physiol Biochem. 115:240–247. 2009. View Article : Google Scholar : PubMed/NCBI
4	Lambelet M, Terra LF, Fukaya M, Meyerovich K, Labriola L, Cardozo AK and Allagnat F: Dysfunctional autophagy following exposure to pro-inflammatory cytokines contributes to pancreatic β-cell apoptosis. Cell Death Dis. 9:962018. View Article : Google Scholar : PubMed/NCBI
5	Berchtold LA, Prause M, Størling J and Mandrup-Poulsen T: Cytokines and Pancreatic β-Cell Apoptosis. Adv Clin Chem. 75:99–158. 2016. View Article : Google Scholar : PubMed/NCBI
6	Ammendrup A, Maillard A, Nielsen K, Aabenhus Andersen N, Serup P, Dragsbaek Madsen O, Mandrup-Poulsen T and Bonny C: The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic β-cells. Diabetes. 49:1468–1476. 2000. View Article : Google Scholar : PubMed/NCBI
7	Kim HE, Choi SE, Lee SJ, Lee JH, Lee YJ, Kang SS, Chun J and Kang Y: Tumour necrosis factor-alpha-induced glucose-stimulated insulin secretion inhibition in INS-1 cells is ascribed to a reduction of the glucose-stimulated Ca²⁺ influx. J Endocrinol. 198:549–560. 2008. View Article : Google Scholar : PubMed/NCBI
8	Størling J, Zaitsev SV, Kapelioukh IL, Karlsen AE, Billestrup N, Berggren PO and Mandrup-Poulsen T: Calcium has a permissive role in interleukin-1β-induced c-jun N-terminal kinase activation in insulin-secreting cells. Endocrinology. 146:3026–3036. 2005. View Article : Google Scholar : PubMed/NCBI
9	Edén D, Siegbahn A and Mokhtari D: Tissue factor/factor VIIa signalling promotes cytokine-induced β cell death and impairs glucose-stimulated insulin secretion from human pancreatic islets. Diabetologia. 58:2563–2572. 2015. View Article : Google Scholar : PubMed/NCBI
10	Verma G, Bhatia H and Datta M: JNK1/2 regulates ER-mitochondrial Ca²⁺ cross-talk during IL-1β-mediated cell death in RINm5F and human primary β-cells. Mol Biol Cell. 24:2058–2071. 2013. View Article : Google Scholar : PubMed/NCBI
11	Wang Q, Zhang H, Zhao B and Fei H: IL-1β caused pancreatic β-cells apoptosis is mediated in part by endoplasmic reticulum stress via the induction of endoplasmic reticulum Ca²⁺ release through the c-Jun N-terminal kinase pathway. Mol Cell Biochem. 324:183–190. 2009. View Article : Google Scholar : PubMed/NCBI
12	Fei H, Zhao B, Zhao S and Wang Q: Requirements of calcium fluxes and ERK kinase activation for glucose- and interleukin-1β-induced β-cell apoptosis. Mol Cell Biochem. 315:75–84. 2008. View Article : Google Scholar : PubMed/NCBI
13	Burke SJ, Goff MR, Updegraff BL, Lu D, Brown PL, Minkin SC Jr, Biggerstaff JP, Zhao L, Karlstad MD and Collier JJ: Regulation of the CCL2 gene in pancreatic β-cells by IL-1β and glucocorticoids: Role of MKP-1. PLoS One. 7:e469862012. View Article : Google Scholar : PubMed/NCBI
14	Niu B, Liu L, Su H, Xia X, He Q, Feng Y, Xue Y and Yan X: Role of extracellular signal regulated kinase 1/2 signal transduction pathway in insulin secretion by β TC6 cells. Mol Med Rep. 13:4451–4454. 2016. View Article : Google Scholar : PubMed/NCBI
15	Niu B, Su H, Xia XS, He Q, Xue YM and Yan XM: The role of interleukin-1β and extracellular signal-regulated kinase 1/2 in glucose-stimulated insulin secretion. Kaohsiung J Med Sci. 33:224–228. 2017. View Article : Google Scholar : PubMed/NCBI
16	Nie Y, Li J, Jin Y, Nyomba BLG, Cattini PA and Vakili H: Negative effects of cyclic palmitate treatment on glucose responsiveness and insulin production in mouse insulinoma Min6 cells Are Reversible. DNA Cell Biol. 38:395–403. 2019. View Article : Google Scholar : PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−ΔΔC(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Anbazhagan K, Rabbind Singh A, Isabelle P, Stella I, Céline AD, Bissac E, Bertrand B, Rémy N, Naomi T, Vincent F, et al: Human pre-B cell receptor signal transduction: Evidence for distinct roles of PI3kinase and MAP-kinase signalling pathways. Immun Inflamm Dis. 1:26–36. 2013. View Article : Google Scholar : PubMed/NCBI
19	Kyriakis JM and Avruch J: Mammalian MAPK signal transduction pathways activated by stress and inflammation: A 10-year update. Physiol Rev. 92:689–737. 2012. View Article : Google Scholar : PubMed/NCBI
20	Singh R and Jwa NS: The rice MAPKK-MAPK interactome: The biological significance of MAPK components in hormone signal transduction. Plant Cell Rep. 32:923–931. 2013. View Article : Google Scholar : PubMed/NCBI
21	Liu Y, Han J, Zhou Z and Li D: Paeoniflorin protects pancreatic β cells from STZ-induced damage through inhibition of the p38 MAPK and JNK signaling pathways. Eur J Pharmacol. 853:18–24. 2019. View Article : Google Scholar : PubMed/NCBI
22	Wei X, Gu N, Feng N, Guo X and Ma X: Inhibition of p38 mitogen-activated protein kinase exerts a hypoglycemic effect by improving β cell function via inhibition of β cell apoptosis in db/db mice. J Enzyme Inhib Med Chem. 33:1494–1500. 2018. View Article : Google Scholar : PubMed/NCBI
23	Lee D, Kim YM, Jung K, Chin YW and Kang KS: Alpha-mangostin improves insulin secretion and protects INS-1 cells from streptozotocin-induced damage. Int J Mol Sci. 19:192018.
24	Carstensen-Kirberg M, Röhrig K, Niersmann C, Ouwens DM, Belgardt BF, Roden M and Herder C: Sfrp5 increases glucose-stimulated insulin secretion in the rat pancreatic β cell line INS-1E. PLoS One. 14:e02136502019. View Article : Google Scholar : PubMed/NCBI
25	Youl E, Bardy G, Magous R, Cros G, Sejalon F, Virsolvy A, Richard S, Quignard JF, Gross R, Petit P, et al: Quercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway. Br J Pharmacol. 161:799–814. 2010. View Article : Google Scholar : PubMed/NCBI
26	Pham MN, Hawa MI, Pfleger C, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum WA, Seissler J, Kolb H, et al Action LADA Study Group, : Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4. Diabetologia. 54:1630–1638. 2011. View Article : Google Scholar : PubMed/NCBI
27	Eizirik DL, Colli ML and Ortis F: The role of inflammation in insulitis and β-cell loss in type 1 diabetes. Nat Rev Endocrinol. 5:219–226. 2009. View Article : Google Scholar : PubMed/NCBI
28	Alexandraki K, Piperi C, Kalofoutis C, Singh J, Alaveras A and Kalofoutis A: Inflammatory process in type 2 diabetes: The role of cytokines. Ann N Y Acad Sci. 1084:89–117. 2006. View Article : Google Scholar : PubMed/NCBI
29	Padgett LE, Broniowska KA, Hansen PA, Corbett JA and Tse HM: The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis. Ann N Y Acad Sci. 1281:16–35. 2013. View Article : Google Scholar : PubMed/NCBI
30	Burke SJ, Stadler K, Lu D, Gleason E, Han A, Donohoe DR, Rogers RC, Hermann GE, Karlstad MD and Collier JJ: IL-1β reciprocally regulates chemokine and insulin secretion in pancreatic β-cells via NF-κB. Am J Physiol Endocrinol Metab. 309:E715–E726. 2015. View Article : Google Scholar : PubMed/NCBI
31	Zhao G, Dharmadhikari G, Maedler K and Meyer-Hermann M: Possible role of interleukin-1β in type 2 diabetes onset and implications for anti-inflammatory therapy strategies. PLOS Comput Biol. 10:e10037982014. View Article : Google Scholar : PubMed/NCBI
32	Corbett JA, Sweetland MA, Lancaster JR Jr and McDaniel ML: A 1-hour pulse with IL-1β induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: Evidence for a tyrosine kinase signaling mechanism. FASEB J. 7:369–374. 1993. View Article : Google Scholar : PubMed/NCBI
33	Weksler-Zangen S, Aharon-Hananel G, Mantzur C, Aouizerat T, Gurgul-Convey E, Raz I and Saada A: IL-1β hampers glucose-stimulated insulin secretion in Cohen diabetic rat islets through mitochondrial cytochrome c oxidase inhibition by nitric oxide. Am J Physiol Endocrinol Metab. 306:E648–E657. 2014. View Article : Google Scholar : PubMed/NCBI
34	Gheibi S, Bakhtiarzadeh F, Jeddi S, Farrokhfall K, Zardooz H and Ghasemi A: Nitrite increases glucose-stimulated insulin secretion and islet insulin content in obese type 2 diabetic male rats. Nitric Oxide. 64:39–51. 2017. View Article : Google Scholar : PubMed/NCBI
35	Rissanen A, Howard CP, Botha J and Thuren T; Global Investigators, : Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: Results of a randomized, placebo-controlled trial. Diabetes Obes Metab. 14:1088–1096. 2012. View Article : Google Scholar : PubMed/NCBI
36	Weaver JR, Grzesik W and Taylor-Fishwick DA: Inhibition of NADPH oxidase-1 preserves β cell function. Diabetologia. 58:113–121. 2015. View Article : Google Scholar : PubMed/NCBI
37	Sabatini PV, Speckmann T and Lynn FC: Friend and foe: Β-cell Ca²⁺ signaling and the development of diabetes. Mol Metab. 21:1–12. 2019. View Article : Google Scholar : PubMed/NCBI
38	Ramadan JW, Steiner SR, O'Neill CM and Nunemaker CS: The central role of calcium in the effects of cytokines on β-cell function: Implications for type 1 and type 2 diabetes. Cell Calcium. 50:481–490. 2011. View Article : Google Scholar : PubMed/NCBI
39	Dula SB, Jecmenica M, Wu R, Jahanshahi P, Verrilli GM, Carter JD, Brayman KL and Nunemaker CS: Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling. Cell Calcium. 48:133–142. 2010. View Article : Google Scholar : PubMed/NCBI
40	Dickerson MT, Bogart AM, Altman MK, Milian SC, Jordan KL, Dadi PK and Jacobson DA: Cytokine-mediated changes in K+ channel activity promotes an adaptive Ca²⁺ response that sustains β-cell insulin secretion during inflammation. Sci Rep. 8:11582018. View Article : Google Scholar : PubMed/NCBI
41	O'Neill CM, Lu C, Corbin KL, Sharma PR, Dula SB, Carter JD, Ramadan JW, Xin W, Lee JK and Nunemaker CS: Circulating levels of IL-1B+IL-6 cause ER stress and dysfunction in islets from prediabetic male mice. Endocrinology. 154:3077–3088. 2013. View Article : Google Scholar : PubMed/NCBI